Metropolis Healthcare Acquires Ambika Pathology Laboratory in Kolhapur

Metropolis Healthcare has acquired Dr. R.S. Patil’s Ambika Pathology Laboratory in Kolhapur for an undisclosed sum. This marks Metropolis’ fourth acquisition in the past 10 months and aligns with its “string of pearls” strategy, aimed at building regional clusters and expanding access to advanced diagnostics across India.

Strengthening the Western Maharashtra Cluster

Founded in 1995, Ambika Pathology Laboratory operates a central laboratory supported by 12 patient touchpoints and offers a comprehensive portfolio of tests. Nearly 75% of its revenue comes from walk-in patients, giving it strong local brand recognition across Kolhapur and nearby towns. This local presence makes it a strategic addition to Metropolis’ Western Maharashtra cluster.

As reported by The Hindu businessline, Metropolis already operates 19 laboratories across Pune, Kolhapur, Sangli, Satara, Solapur, Nashik, and Ahmednagar. Over 200 patient service centres and a growing franchise network support these laboratories. This network enables Metropolis to deliver advanced diagnostics to a wider population.

Maharashtra as a Key Growth Market

Ameera Shah, Promoter and Executive Chairperson of Metropolis Healthcare, emphasized Maharashtra’s importance, saying:
“Maharashtra continues to be a key growth market for Metropolis, contributing nearly 40% of our total revenues. The acquisition of Ambika Pathology further strengthens our Western Maharashtra cluster and supports our ambition to make high-quality diagnostics accessible to more communities.”

Also Read |  GBS Cases in Pune Rise to 111; Health Authorities Investigate Possible Link to Contaminated Water

Ambika to Become a Mini Regional Reference Centre

Surendran Chemmenkotil, Managing Director of Metropolis Healthcare, highlighted the strategic value of the acquisition:
“Kolhapur is an important healthcare hub, and the integration of Ambika Pathology Laboratory provides a formidable base to serve patients and clinicians more comprehensively. Ambika’s facility will be developed into a mini regional reference lab, strengthening our specialised diagnostics capabilities in the region.”

Collaboration to Enhance Test Portfolio and Opportunities

Dr. Rajendra Patil, Founder of Ambika Pathology Laboratory, expressed optimism about the collaboration. He stated that it would expand the availability of specialised tests in Kolhapur. The partnership would also create new opportunities for medical professionals and patients to benefit from advanced diagnostic innovations.